Skip to content
Search

Latest Stories

HEE announces new Independent Prescriber courses for pharmacists

Health Education England (HEE) has announced launch of a new funded Independent Prescriber courses for pharmacists to be made available before March 2022.

Places are available for both Independent Prescribing (IP) and Clinically Enhanced Independent Prescribing (CEPIP), and eligible pharmacists are encouraged to apply to the course providers directly.


This follows NHS England and NHS Improvement’s announcement in November 2021 that the Pharmacy Integration Programme would invest up to £15.9 million over the next four years to boost pharmacy professional career development.

These courses will be allocated on a first come, first served basis, and a further round of funded Independent Prescriber training will be made available from Autumn 2022.

The independent prescriber guide offers practical guidance and support on the prescriber role, such as how to become an independent prescriber, applying for an IP course, or expanding the scope of practice.

Besides, practical guidance on issues such as finding a Designated Prescribing Practitioner, repeat prescribing, and prescribing safely and legally will also be offered.

Commenting on the announcement, Alastair Buxton, director of NHS Services at PSNC, said: “Independent prescribing will be at the heart of many future developments in community pharmacy services, so this initial offer is a welcome start to support community pharmacists to develop their skills, particularly those who were already planning to commence training early in 2022.

“HEE are now putting in place the next phase of this IP training programme, so there will be many more opportunities for pharmacists to access training later in the year.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less